GlassScriptPhysician profile
Mareeni T Stanislaus
NPI 1730105123
$2,263.51
in general payments reported to CMS, 2019-2025
20 companies · $495 in 2025
The $495 reported for 2025 was more than what 80% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $187 · 2020: $105 · 2021: $138 · 2022: $519 · 2023: $275 · 2024: $545 · 2025: $495.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,315.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,314.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Revance Therapeutics, INC. | $536.81 | 2024-2025 | Daxxify |
| Abbvie INC. | $515.65 | 2019-2025 | Botox, Ubrelvy |
| Allergan, INC. | $298.20 | 2020-2022 | |
| Hologic Sales and Service, LLC | $254.31 | 2022-2025 | Myosure Tissue Removal Device, Acessa Provu System, Coolseal Generator |
| Coloplast Corp | $179.88 | 2019-2024 | Saffron |
| Dexcom, INC. | $143.49 | 2025 | Dexcom Stelo Glucose Biosensor, Dexcom G7 Gss (161), Dexcom G6 Transmitter |
| Therapeuticsmd, INC. | $47.83 | 2019-2020 | |
| Amag Pharmaceuticals, INC. | $39.88 | 2019 | |
| Merz North America, INC. | $36.87 | 2023 | Xeomin |
| Ethicon US, LLC | $26.28 | 2023 | Harmonic |
| Alydia Health | $22.39 | 2021 | |
| Exact Sciences Corporation | $21.93 | 2023 | Cologuard Collection Kit |
| Sumitomo Pharma America, INC. | $20.31 | 2024 | Myfembree |
| Astellas Pharma US INC | $19.37 | 2024 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $18.90 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myriad Women'S Health, INC. | $18.54 | 2023 | Myrisk |
| Channel Medsystems, INC. | $18.32 | 2023 | |
| Evofem Biosciences, INC. | $16.54 | 2022 | |
| Organon LLC | $16.02 | 2025 | Nexplanon |
| Pfizer INC. | $11.99 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mareeni Stanislaus listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.